- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus, Type 2 in Ireland
Total 437 results
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, United Kingdom, Canada, Sweden, Ireland, Argentina, Brazil, Lebanon, Malaysia, Mexico, Italy
-
Mannkind CorporationCompletedDiabetes Type 2Brazil, Spain, United States, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Germany, United Kingdom, Austria, Belgium, France, Ireland
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 4United States, Argentina, Brazil, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Brazil, Greece, Argentina, Korea, Republic of, Czechia, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, Mexico, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 3United States, Argentina, Brazil, Canada, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United Kingdom, Finland, Norway, Canada, Mexico, Argentina, Brazil, United States
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Karl NeffUniversity College DublinCompletedDiabetic Kidney DiseaseIreland
-
Eli Lilly and CompanyOPKO Health, Inc.CompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Spain, Denmark, Austria, Belgium, Serbia, Germany, Slovenia, Canada, France, Finland, Former Serbia and Montenegro, Czech Republic, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, United Kingdom, Ireland, France, South Africa, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Denmark, Sweden, Austria, Germany, Macedonia, The Former Yugoslav Republic of, Slovenia, France, Switzerland, Norway, Spain, Ireland, Finland, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, Poland, Russian Federation, Spain, Canada, Denmark, Taiwan, Malaysia, United Kingdom, Turkey, Germany, Bulgaria, Argentina, Australia, Thailand, Algeria, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Argentina, Thailand, India, Korea, Republic of
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Japan, Puerto Rico, Serbia, Germany
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Russian Federation, Slovakia, Spain, Canada, Taiwan, Finland, Hungary, Malaysia, South Africa, United Kingdom, Germany, Australia, Thailand, Ireland, Puerto Rico, Singapore
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia, India, Italy, Russian Federation, Spain, Denmark, United Kingdom, Sweden, Belgium, Ireland, Argentina, Hungary, Norway, South Africa, Germany, Croatia, Netherlands, Bulgaria, Australia, Romania
-
Forest LaboratoriesPhenomixTerminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, India, Philippines
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Slovakia, Spain, United Kingdom, Finland, Ireland, Germany, Greece, Puerto Rico, Romania, Bulgaria, Latvia, Hong Kong, Lithuania, Portugal
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Israel, Italy, Mexico, Puerto Rico, Russian Federation, Spain, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Taiwan, Finland, Norway, Serbia, South Africa, Turkey, Canada, France, Germany, Korea, Republic of and more